CH603681A5 - - Google Patents

Info

Publication number
CH603681A5
CH603681A5 CH613674A CH613674A CH603681A5 CH 603681 A5 CH603681 A5 CH 603681A5 CH 613674 A CH613674 A CH 613674A CH 613674 A CH613674 A CH 613674A CH 603681 A5 CH603681 A5 CH 603681A5
Authority
CH
Switzerland
Application number
CH613674A
Inventor
Richard Elmer Holmes
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH603681A5 publication Critical patent/CH603681A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
CH613674A 1973-05-22 1974-05-06 CH603681A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US362700A US3903071A (en) 1973-05-22 1973-05-22 Mycophenolic acid derivatives

Publications (1)

Publication Number Publication Date
CH603681A5 true CH603681A5 (fr) 1978-08-31

Family

ID=23427173

Family Applications (1)

Application Number Title Priority Date Filing Date
CH613674A CH603681A5 (fr) 1973-05-22 1974-05-06

Country Status (24)

Country Link
US (1) US3903071A (fr)
JP (1) JPS5019747A (fr)
AR (1) AR201234A1 (fr)
AT (1) AT337892B (fr)
BE (1) BE815330A (fr)
BG (1) BG25994A3 (fr)
CA (1) CA1027558A (fr)
CH (1) CH603681A5 (fr)
CS (1) CS187435B2 (fr)
DD (1) DD113544A5 (fr)
DE (1) DE2424119A1 (fr)
ES (1) ES426543A1 (fr)
FR (1) FR2230361B1 (fr)
GB (1) GB1465008A (fr)
HU (1) HU169191B (fr)
IE (1) IE39218B1 (fr)
IL (1) IL44670A (fr)
NL (1) NL7406542A (fr)
PH (1) PH10898A (fr)
PL (1) PL89967B1 (fr)
RO (1) RO68642A (fr)
SE (1) SE7908625L (fr)
SU (1) SU578006A3 (fr)
ZA (1) ZA742417B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5414176Y2 (fr) * 1971-05-31 1979-06-13
US4103006A (en) * 1976-05-20 1978-07-25 Wisconsin Alumni Research Foundation Glycosides of 2,6-bis(hydroxy-phenyl)-3,7-dioxabicyclo [3,3,0] octane
US4686234A (en) * 1985-11-27 1987-08-11 Syntex (U.S.A) Inc. Mycophenolic acid derivatives in the treatment of inflammatory diseases, in particular rheumatoid arthritis
US4725622A (en) * 1986-01-23 1988-02-16 Syntex (U.S.A.) Inc. Mycophenolic acid derivatives in the treatment of rheumatoid arthritis
US5177072A (en) * 1987-01-30 1993-01-05 Syntex (U.S.A.) Inc. Treatment of autoimmune inflammatory, and psoriatic diseases with heterocyclic aminoalkyl esters of mycophenolic acid and derivatives
US4753935A (en) * 1987-01-30 1988-06-28 Syntex (U.S.A.) Inc. Morpholinoethylesters of mycophenolic acid and pharmaceutical compositions
JPH0736475Y2 (ja) * 1987-05-14 1995-08-16 阪神エレクトリック株式会社 インバ−タ装置
US5098899A (en) * 1989-03-06 1992-03-24 Trustees Of Boston University Method for therapeutically treating psoriatic arthritis using vitamin D analogues and metabolites
US5455045A (en) * 1993-05-13 1995-10-03 Syntex (U.S.A.) Inc. High dose formulations
ID18663A (id) * 1996-04-12 1998-04-30 Novartis Ag Komposisi farmasi berlapis enterik
US6471980B2 (en) 2000-12-22 2002-10-29 Avantec Vascular Corporation Intravascular delivery of mycophenolic acid
US20050203612A1 (en) * 2000-12-22 2005-09-15 Avantec Vascular Corporation Devices delivering therapeutic agents and methods regarding the same
US20030050692A1 (en) * 2000-12-22 2003-03-13 Avantec Vascular Corporation Delivery of therapeutic capable agents
US7083642B2 (en) * 2000-12-22 2006-08-01 Avantec Vascular Corporation Delivery of therapeutic capable agents
US7077859B2 (en) * 2000-12-22 2006-07-18 Avantec Vascular Corporation Apparatus and methods for variably controlled substance delivery from implanted prostheses
AU2002327358A1 (en) * 2001-07-26 2003-02-17 Avantec Vascular Corporation Methods and devices for delivery of therapeutic capable agents with variable release profile
US6641611B2 (en) 2001-11-26 2003-11-04 Swaminathan Jayaraman Therapeutic coating for an intravascular implant
WO2005051229A2 (fr) * 2003-11-24 2005-06-09 Avantec Vascular Corporation Dispositifs et procedes d'administration d'agents therapeutiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758455A (en) * 1970-05-14 1973-09-11 Chugai Pharmaceutical Co Ltd Reof mycophenolic acid glucuronide and the process for the preparation the

Also Published As

Publication number Publication date
BE815330A (fr) 1974-11-21
AR201234A1 (es) 1975-02-21
JPS5019747A (fr) 1975-03-01
US3903071A (en) 1975-09-02
FR2230361A1 (fr) 1974-12-20
IE39218L (en) 1974-11-22
HU169191B (fr) 1976-10-28
SE7908625L (sv) 1979-10-17
IE39218B1 (en) 1978-08-30
IL44670A0 (en) 1974-06-30
SU578006A3 (ru) 1977-10-25
PH10898A (en) 1977-09-30
AT337892B (de) 1977-07-25
CA1027558A (fr) 1978-03-07
ZA742417B (en) 1975-11-26
BG25994A3 (fr) 1979-01-12
NL7406542A (fr) 1974-11-26
RO68642A (fr) 1980-06-15
IL44670A (en) 1977-08-31
FR2230361B1 (fr) 1977-01-28
CS187435B2 (en) 1979-01-31
PL89967B1 (fr) 1976-12-31
DE2424119A1 (de) 1974-12-12
DD113544A5 (fr) 1975-06-12
AU6802774A (en) 1975-10-23
ES426543A1 (es) 1976-07-01
GB1465008A (en) 1977-02-16
ATA421274A (de) 1976-11-15

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU476761B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
AU474593B2 (fr)
AU474838B2 (fr)
JPS5019747A (fr)
AR201229Q (fr)
AU477823B2 (fr)
AR201432A1 (fr)
AR200256A1 (fr)
AR200885A1 (fr)
AR197627A1 (fr)
AR196382A1 (fr)
AR193950A1 (fr)
AR195948A1 (fr)
AR195311A1 (fr)
AU476873B1 (fr)
AR210729A1 (fr)
AU477824B2 (fr)
AR196212Q (fr)
AR196123Q (fr)
CH559509A5 (fr)
AU479522A (fr)
CH560984A5 (fr)

Legal Events

Date Code Title Description
PL Patent ceased